Dangerous Drugs Lawsuits Information
It is estimated that every year approximately 200,000
Americans die from prescription drug adverse reactions and side effects. In
fact, it is widely believed that more Americans die as a result of prescription
drug interactions or side effects that from using illegal drugs. Furthermore,
thousands of Americans are seriously injured and sometimes die from adverse
reactions and side effects associated with common over-the-counter medications.
The Federal Food and Drug Administration (FDA) is under constant pressure from
drug manufacturers to approve drugs quickly, which in many cases proves to be
premature. Many prescription drugs that undergo FDA review, are given “fast
track” status which greatly reduces the time it usually takes to get drugs
approved. Often, the end result is drugs are approved before all the side
effects are noticed and can ultimately do much greater harm than good.
Some drugs have been withdrawn from the market subsequently
to their introduction due to risks for the patients. Usually this has been due
to unexpected adverse effects that were not detected during Phase III clinical
trials and were only apparent from post-marketing surveillance data from the
wider patient community.
* thalidomide (1950s-1960s) - withdrawn due to risk of teratogenicity; returned
to market as an anti-neoplastic drug under FDA orphan drug rules
* diethylstilbestrol (1970s) - withdrawn due to risk of teratogenicity
* phenformin and buformin - withdrawn due to risk of lactic acidosis
* ticrynafen (1982) - withdrawn due to risk of hepatitis
* methaqualone (1984) - withdrawn due to risk of addiction and overdose.
* triazolam (1991) - withdrawn in the United Kingdom due to risk of psychiatric
adverse drug reactions
* Fen-phen - popular combination of fenfluramine and phentermine; phentermine
remains on the market, dexfenfluramine & fenfluramine (1997) later withdrawn
* lysergic acid diethylamide (LSD) (1950s-1960s), marketed as a psychiatric
cure-all; withdrawn after it became widely used recreationally by hippies
* terfenadine (1998) - withdrawn due to risk of cardiac arrhythmias; superseded
by fexofenadine
* mibefradil (1998) - withdrawn due to dangerous interactions with other drugs
* troglitazone (2000) - withdrawn due to risk of hepatotoxicity; superseded by
pioglitazone and rosiglitazone
* alosetron (2000) - withdrawn due to risk of fatal complications of
constipation; reintroduced 2002 on a restricted basis
* cisapride (2000s) - withdrawn in many countries due to risk of cardiac
arrhythmias
* cerivastatin (2001) - withdrawn due to risk of rhabdomyolysis
* rapacuronium (2001) - withdrawn in many countries due to risk of fatal
bronchospasm
* rofecoxib (Bextra) (2004) - withdrawn due to risk of myocardial infarction
For more free legal information on known dangerous drugs and Dangerous Drugs Lawsuits, please use the
links below:
|
